title: On the introduction of genetically modified Leishmania outside the laboratory.
authors.affiliation: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.
authors.forename: F J
authors.initials: FJ
authors.lastname: Gueiros-Filho
authors.forename: S M
authors.initials: SM
authors.lastname: Beverley
mesh_terms: D000818:Animals; D004351:Drug Resistance / Q000235:genetics; D005786:Gene Expression Regulation; D017125:Genes, Protozoan; D005818:Genetic Engineering; D005819:Genetic Markers; D019868:Kanamycin Kinase; D018320:Leishmania major / Q000187:drug effects / Q000235:genetics* / Q000276:immunology; D010303:Paromomycin / Q000494:pharmacology; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics; D016052:Protozoan Vaccines / Q000235:genetics; D014162:Transfection; D014613:Vaccines, Attenuated / Q000235:genetics
chemical_list: D005819:Genetic Markers; D016052:Protozoan Vaccines; D014613:Vaccines, Attenuated; D010303:Paromomycin; D017853:Phosphotransferases (Alcohol Group Acceptor); C063242:hygromycin-B kinase; D019868:Kanamycin Kinase